✦ LIBER ✦

PMH1 COST-EFFECTIVENESS OF CLINICALLY PROVEN TREATMENT STRATEGIES FOR ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD): IMPACT OF COEXISTING CONDITIONS

✍ Scribed by M Schlander; O Schwarz; EM Foster; L Hakkaart-van Roijen; PS Jensen; U Persson; PJ Santosh; GE Trott; MTA CooperativeTA; O Group

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH9 COST-EFFECTIVENESS OF CLINICALLY PR

✍ M Schlander; O Schwarz; L Hakkaart-van Roijen; PS Jensen; U Persson; PJ Santosh; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

PIH29 the Cost Effectiveness of Clinical

✍ M. Schlander; A. Philipsen; O. Schwarz 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PMH40 COST-EFFECTIVENESS OF RITALINTM VE

✍ S Narayan; JW Hay 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PMH10 FUNCTIONAL IMPAIRMENT OF PATIENTS

✍ M Schlander; O Schwarz; L Hakkaart-van Roijen; PS Jensen; U Persson; PJ Santosh; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

PMH37 THE COST-EFFECTIVENESS OF GUANFACI

✍ Erder, M.; Chen, K.; Wu, E.Q.; Hodgkins, P.; Sikirica, V. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Cost-effectiveness of dexamphetamine and

✍ Marie Donnelly; Michelle M. Haby; Rob Carter; Gavin Andrews; Theo Vos 📂 Article 📅 2004 🏛 Informa plc 🌐 English ⚖ 250 KB